FeesSafety
Pluang+

Bitcoin options open interest stays near $25B with bullish call dominance signaling cautious optimism.

Market News
09 Aug 2026
Tokenpost
View Source
Bullish
Bitcoin options open interest stays near $25B with bullish call dominance signaling cautious optimism.

Bitcoin options open interest remains steady near $25.33 billion, with call options making up about 60% of total open interest, indicating a bullish bias among traders. Trading volume favors calls over puts, reflecting a short-term optimistic outlook despite stable overall positioning. Key contract expiries show a mix of bullish and protective strategies, suggesting traders are preparing for potential price swings while maintaining cautious optimism.

More News

Fortrea and Omico partner to accelerate biomarker-led cancer drug trials in Australia

Fortrea and Omico partner to accelerate biomarker-led cancer drug trials in Australia

Fortrea Holdings and Omico have formed a partnership to enhance precision oncology research in Australia by linking cancer patients to biomarker-matched clinical trials. This collaboration combines Fortrea's oncology trial expertise with Omico's Prec...

Market News
Bullish
1 hour ago
Fortrea and Omico partner to speed biomarker-based cancer drug trials in Australia

Fortrea and Omico partner to speed biomarker-based cancer drug trials in Australia

Fortrea Holdings Inc and Omico have formed a partnership to accelerate precision oncology research in Australia by connecting cancer patients to biomarker-driven clinical trials. The collaboration combines Fortrea's expertise in oncology clinical tri...

Market News
Bullish
1 hour ago
Fortrea and Omico partner to speed biomarker-based cancer drug trials in Australia

Fortrea and Omico partner to speed biomarker-based cancer drug trials in Australia

Fortrea Holdings and Omico have formed a partnership to accelerate precision oncology research in Australia by combining Fortrea's clinical trial expertise with Omico's Precision Oncology Screening Platform (PrOSPeCT). This collaboration aims to impr...

Market News
Bullish
1 hour ago
Fortrea and Omico partner to accelerate biomarker-driven cancer drug trials in Australia

Fortrea and Omico partner to accelerate biomarker-driven cancer drug trials in Australia

Fortrea Holdings Inc and Omico have formed a partnership to enhance precision oncology research in Australia by matching cancer patients with biomarker-driven clinical trials. This collaboration combines Fortrea's expertise in oncology clinical trial...

Market News
Bullish
1 hour ago
Fortrea and Omico partner to enhance biomarker-driven cancer drug trials in Australia

Fortrea and Omico partner to enhance biomarker-driven cancer drug trials in Australia

Fortrea Holdings and Omico have formed a partnership to accelerate precision oncology research by improving biomarker-based clinical trial planning and patient recruitment in Australia. The collaboration leverages Fortrea's clinical trial expertise a...

Market News
Bullish
1 hour ago
banner-footerbanner-footer

Invest & Trade with
#1 Award-Winning Investment Super App